Forecasting the impact of heart failure in the united states a policy statement from the american heart association

Paul A. Heidenreich, Nancy M. Albert, Larry A. Allen, David A. Bluemke, Javed Butler, Gregg C. Fonarow, John S. Ikonomidis, Olga Khavjou, Marvin A. Konstam, Thomas M. Maddox, Graham Nichol, Michael Pham, Ileana L. Pina, Justin G. Trogdon

Research output: Contribution to journalArticle

1000 Citations (Scopus)

Abstract

Background-Heart failure (HF) is an important contributor to both the burden and cost of national healthcare expenditures, with more older Americans hospitalized for HF than for any other medical condition. With the aging of the population, the impact of HF is expected to increase substantially. Methods and Results-We estimated future costs of HF by adapting a methodology developed by the American Heart Association to project the epidemiology and future costs of HF from 2012 to 2030 without double counting the costs attributed to comorbid conditions. The model assumes that HF prevalence will remain constant by age, sex, and race/ ethnicity and that rising costs and technological innovation will continue at the same rate. By 2030, >8 million people in the United States (1 in every 33) will have HF. Between 2012 and 2030, real (2010$) total direct medical costs of HF are projected to increase from $21 billion to $53 billion. Total costs, including indirect costs for HF, are estimated to increase from $31 billion in 2012 to $70 billion in 2030. If one assumes all costs of cardiac care for HF patients are attributable to HF (no cost attribution to comorbid conditions), the 2030 projected cost estimates of treating patients with HF will be 3-fold higher ($160 billion in direct costs). Conclusions-The estimated prevalence and cost of care for HF will increase markedly because of aging of the population. Strategies to prevent HF and improve the efficiency of care are needed.

Original languageEnglish (US)
Pages (from-to)606-619
Number of pages14
JournalCirculation: Heart Failure
Volume6
Issue number3
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

American Heart Association
Heart Failure
Costs and Cost Analysis
Inventions
Health Expenditures
Health Care Costs

Keywords

  • AHA Scientific Statements
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., Fonarow, G. C., ... Trogdon, J. G. (2013). Forecasting the impact of heart failure in the united states a policy statement from the american heart association. Circulation: Heart Failure, 6(3), 606-619. https://doi.org/10.1161/HHF.0b013e318291329a

Forecasting the impact of heart failure in the united states a policy statement from the american heart association. / Heidenreich, Paul A.; Albert, Nancy M.; Allen, Larry A.; Bluemke, David A.; Butler, Javed; Fonarow, Gregg C.; Ikonomidis, John S.; Khavjou, Olga; Konstam, Marvin A.; Maddox, Thomas M.; Nichol, Graham; Pham, Michael; Pina, Ileana L.; Trogdon, Justin G.

In: Circulation: Heart Failure, Vol. 6, No. 3, 05.2013, p. 606-619.

Research output: Contribution to journalArticle

Heidenreich, PA, Albert, NM, Allen, LA, Bluemke, DA, Butler, J, Fonarow, GC, Ikonomidis, JS, Khavjou, O, Konstam, MA, Maddox, TM, Nichol, G, Pham, M, Pina, IL & Trogdon, JG 2013, 'Forecasting the impact of heart failure in the united states a policy statement from the american heart association', Circulation: Heart Failure, vol. 6, no. 3, pp. 606-619. https://doi.org/10.1161/HHF.0b013e318291329a
Heidenreich, Paul A. ; Albert, Nancy M. ; Allen, Larry A. ; Bluemke, David A. ; Butler, Javed ; Fonarow, Gregg C. ; Ikonomidis, John S. ; Khavjou, Olga ; Konstam, Marvin A. ; Maddox, Thomas M. ; Nichol, Graham ; Pham, Michael ; Pina, Ileana L. ; Trogdon, Justin G. / Forecasting the impact of heart failure in the united states a policy statement from the american heart association. In: Circulation: Heart Failure. 2013 ; Vol. 6, No. 3. pp. 606-619.
@article{d3bbd5a013a74651b20a50841ea3f429,
title = "Forecasting the impact of heart failure in the united states a policy statement from the american heart association",
abstract = "Background-Heart failure (HF) is an important contributor to both the burden and cost of national healthcare expenditures, with more older Americans hospitalized for HF than for any other medical condition. With the aging of the population, the impact of HF is expected to increase substantially. Methods and Results-We estimated future costs of HF by adapting a methodology developed by the American Heart Association to project the epidemiology and future costs of HF from 2012 to 2030 without double counting the costs attributed to comorbid conditions. The model assumes that HF prevalence will remain constant by age, sex, and race/ ethnicity and that rising costs and technological innovation will continue at the same rate. By 2030, >8 million people in the United States (1 in every 33) will have HF. Between 2012 and 2030, real (2010$) total direct medical costs of HF are projected to increase from $21 billion to $53 billion. Total costs, including indirect costs for HF, are estimated to increase from $31 billion in 2012 to $70 billion in 2030. If one assumes all costs of cardiac care for HF patients are attributable to HF (no cost attribution to comorbid conditions), the 2030 projected cost estimates of treating patients with HF will be 3-fold higher ($160 billion in direct costs). Conclusions-The estimated prevalence and cost of care for HF will increase markedly because of aging of the population. Strategies to prevent HF and improve the efficiency of care are needed.",
keywords = "AHA Scientific Statements, Heart failure",
author = "Heidenreich, {Paul A.} and Albert, {Nancy M.} and Allen, {Larry A.} and Bluemke, {David A.} and Javed Butler and Fonarow, {Gregg C.} and Ikonomidis, {John S.} and Olga Khavjou and Konstam, {Marvin A.} and Maddox, {Thomas M.} and Graham Nichol and Michael Pham and Pina, {Ileana L.} and Trogdon, {Justin G.}",
year = "2013",
month = "5",
doi = "10.1161/HHF.0b013e318291329a",
language = "English (US)",
volume = "6",
pages = "606--619",
journal = "Circulation: Heart Failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Forecasting the impact of heart failure in the united states a policy statement from the american heart association

AU - Heidenreich, Paul A.

AU - Albert, Nancy M.

AU - Allen, Larry A.

AU - Bluemke, David A.

AU - Butler, Javed

AU - Fonarow, Gregg C.

AU - Ikonomidis, John S.

AU - Khavjou, Olga

AU - Konstam, Marvin A.

AU - Maddox, Thomas M.

AU - Nichol, Graham

AU - Pham, Michael

AU - Pina, Ileana L.

AU - Trogdon, Justin G.

PY - 2013/5

Y1 - 2013/5

N2 - Background-Heart failure (HF) is an important contributor to both the burden and cost of national healthcare expenditures, with more older Americans hospitalized for HF than for any other medical condition. With the aging of the population, the impact of HF is expected to increase substantially. Methods and Results-We estimated future costs of HF by adapting a methodology developed by the American Heart Association to project the epidemiology and future costs of HF from 2012 to 2030 without double counting the costs attributed to comorbid conditions. The model assumes that HF prevalence will remain constant by age, sex, and race/ ethnicity and that rising costs and technological innovation will continue at the same rate. By 2030, >8 million people in the United States (1 in every 33) will have HF. Between 2012 and 2030, real (2010$) total direct medical costs of HF are projected to increase from $21 billion to $53 billion. Total costs, including indirect costs for HF, are estimated to increase from $31 billion in 2012 to $70 billion in 2030. If one assumes all costs of cardiac care for HF patients are attributable to HF (no cost attribution to comorbid conditions), the 2030 projected cost estimates of treating patients with HF will be 3-fold higher ($160 billion in direct costs). Conclusions-The estimated prevalence and cost of care for HF will increase markedly because of aging of the population. Strategies to prevent HF and improve the efficiency of care are needed.

AB - Background-Heart failure (HF) is an important contributor to both the burden and cost of national healthcare expenditures, with more older Americans hospitalized for HF than for any other medical condition. With the aging of the population, the impact of HF is expected to increase substantially. Methods and Results-We estimated future costs of HF by adapting a methodology developed by the American Heart Association to project the epidemiology and future costs of HF from 2012 to 2030 without double counting the costs attributed to comorbid conditions. The model assumes that HF prevalence will remain constant by age, sex, and race/ ethnicity and that rising costs and technological innovation will continue at the same rate. By 2030, >8 million people in the United States (1 in every 33) will have HF. Between 2012 and 2030, real (2010$) total direct medical costs of HF are projected to increase from $21 billion to $53 billion. Total costs, including indirect costs for HF, are estimated to increase from $31 billion in 2012 to $70 billion in 2030. If one assumes all costs of cardiac care for HF patients are attributable to HF (no cost attribution to comorbid conditions), the 2030 projected cost estimates of treating patients with HF will be 3-fold higher ($160 billion in direct costs). Conclusions-The estimated prevalence and cost of care for HF will increase markedly because of aging of the population. Strategies to prevent HF and improve the efficiency of care are needed.

KW - AHA Scientific Statements

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=84879202874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879202874&partnerID=8YFLogxK

U2 - 10.1161/HHF.0b013e318291329a

DO - 10.1161/HHF.0b013e318291329a

M3 - Article

VL - 6

SP - 606

EP - 619

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3297

IS - 3

ER -